The global precision medicine software market is valued at $1.2 billion in 2018 and is expected to reach $2.8 billion by 2026 and is expected to grow at a CAGR of 11% from 2021 to 2027. The global precision medicine software market is attributable to increasing cooperation between research institutions and enterprises in the near future, increasing licensing agreements and partnerships between enterprises, and increasing R&D investment in precision medicine.
A full report of Precision Medicine Software Market available at https://www.orionmarketreports.com/precision-medicine-software-market/11601/
The key players of the precision medicine software market such as Synapse, Inc., Allscripts Healthcare Solutions, Inc. (2bPrecise LLC), Roche Holdings, Inc. (Foundation Medicine, Inc.), Fabric Genomics, Inc., Sophia Genetics SA, PierianDx, Inc., Qiagen N.V. (N-of-One, Inc.), Human Longevity, Inc., Roper Technologies, Inc. (Sunquest Information Systems, Inc.), Gene42, Inc. Other players in the value chain include Translational Software, Inc., LifeOmic Health, LLC, NantHealth, Inc., Tempus Labs, Inc., Flatiron Health, Inc., IBM Watson Group, and Koninklijke Philips N.V.
Precision Medicine Software Market Segmentations
By delivery mode
• On-premise Delivery Mode
• Cloud-based Delivery Mode
By end user
• Healthcare Providers
• Research Centers and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Other End Users (non-profit organizations and diagnostic companies)
By application
• Oncology
• Pharmacogenomics
• Rare Diseases
• Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
